Investigational Nasal Spray Modestly Reduces OSA Severity
Researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of OSA and next-day blood pressure.
Researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of OSA and next-day blood pressure.
Researchers are developing a COVID nasal spray to inhibit SARS-CoV-2 infection. The newly discovered small molecule N-0385 could be sprayed into people’s noses to prevent COVID-19 illness.
Administering medications through the nose as an alternative to injections or IVs is becoming increasingly popular in emergency departments and ambulances.